Buyers must provide the specific active pharmaceutical ingredient (API) strength, exact dosage form, desired packaging (blister/bottle), target market registration requirements (such as CTD/ACTD dossier format), and the projected annual or per-batch order volume.
Category market report
Anti-Infective Drugs
Total suppliers
7,685+
Total Chinese suppliers export
$13.5B+
Recommended
High-quality suppliers related to Anti-Infective Drugs.
Suppliers
Find more suppliers who may be worth contacting.
Top suppliers
Suppliers in this category.
- Transactions
1,897
2018-012022-032026-08Transaction trend for Astrazeneca Pharmaceutical Co., Ltd.
- 2018-01: 4
- 2018-02: 2
- 2018-03: 3
- 2018-04: 4
- 2018-05: 3
- 2018-06: 10
- 2018-07: 5
- 2018-09: 10
- 2018-10: 2
- 2018-11: 1
- 2018-12: 1
- 2019-01: 32
- 2019-02: 19
- 2019-03: 17
- 2019-04: 13
- 2019-05: 19
- 2019-06: 16
- 2019-07: 9
- 2019-08: 5
- 2019-09: 4
- 2019-10: 7
- 2019-11: 13
- 2019-12: 15
- 2020-01: 24
- 2020-02: 1
- 2020-03: 18
- 2020-04: 30
- 2020-05: 27
- 2020-06: 14
- 2020-07: 13
- 2020-08: 38
- 2020-09: 4
- 2020-10: 21
- 2020-11: 28
- 2020-12: 16
- 2021-01: 9
- 2021-02: 42
- 2021-03: 23
- 2021-04: 20
- 2021-05: 44
- 2021-06: 23
- 2021-07: 19
- 2021-08: 33
- 2021-09: 15
- 2021-10: 46
- 2021-11: 27
- 2021-12: 22
- 2022-01: 43
- 2022-02: 9
- 2022-03: 22
- 2022-04: 30
- 2022-05: 24
- 2022-06: 26
- 2022-07: 19
- 2022-08: 18
- 2022-09: 19
- 2022-10: 34
- 2022-11: 12
- 2022-12: 37
- 2023-01: 13
- 2023-02: 19
- 2023-03: 51
- 2023-04: 22
- 2023-05: 12
- 2023-06: 26
- 2023-07: 23
- 2023-08: 17
- 2023-09: 45
- 2023-10: 10
- 2023-11: 32
- 2023-12: 15
- 2024-02: 28
- 2024-03: 12
- 2024-05: 31
- 2024-06: 18
- 2024-07: 16
- 2024-08: 6
- 2024-09: 15
- 2024-10: 16
- 2024-11: 11
- 2024-12: 14
- 2025-01: 21
- 2025-02: 14
- 2025-03: 19
- 2025-04: 13
- 2025-05: 9
- 2025-06: 11
- 2025-07: 20
- 2025-08: 17
- 2025-09: 13
- 2025-10: 7
- 2025-11: 13
- 2025-12: 16
- 2026-01: 21
- 2026-03: 13
- 2026-04: 49
- 2026-05: 33
- 2026-06: 25
- 2026-07: 28
- 2026-08: 14
- Amount
4,100,621.13
2018-012022-032026-08Amount trend for Astrazeneca Pharmaceutical Co., Ltd.
- 2018-01: 19.5M
- 2018-02: 23.3K
- 2018-03: 613.5K
- 2018-04: 401K
- 2018-05: 53.6K
- 2018-06: 195.8K
- 2018-07: 174.2K
- 2018-09: 1.4M
- 2018-10: 143.4K
- 2018-11: 27.6K
- 2018-12: 23K
- 2019-01: 40.7B
- 2019-02: 2.8M
- 2019-03: 2.4M
- 2019-04: 1.7M
- 2019-05: 2.6M
- 2019-06: 3.1M
- 2019-07: 1.8M
- 2019-08: 840.4K
- 2019-09: 772.1K
- 2019-10: 2.5M
- 2019-11: 2M
- 2019-12: 1.8M
- 2020-01: 7M
- 2020-02: 9,942.19
- 2020-03: 3.1M
- 2020-04: 4.1M
- 2020-05: 4.5M
- 2020-06: 5.9M
- 2020-07: 2.1M
- 2020-08: 7.6M
- 2020-09: 281.4K
- 2020-10: 1.8M
- 2020-11: 2.3M
- 2020-12: 2.1M
- 2021-01: 927.7K
- 2021-02: 5.9M
- 2021-03: 3M
- 2021-04: 2.8M
- 2021-05: 6.3M
- 2021-06: 4.1M
- 2021-07: 2.5M
- 2021-08: 4M
- 2021-09: 3.4M
- 2021-10: 7M
- 2021-11: 3.9M
- 2021-12: 4M
- 2022-01: 8.5M
- 2022-02: 2.3M
- 2022-03: 2.2M
- 2022-04: 5.2M
- 2022-05: 2.8M
- 2022-06: 4.1M
- 2022-07: 3.3M
- 2022-08: 2.1M
- 2022-09: 2.8M
- 2022-10: 5.3M
- 2022-11: 2M
- 2022-12: 5.9M
- 2023-01: 1.2M
- 2023-02: 3.3M
- 2023-03: 6.5M
- 2023-04: 3.4M
- 2023-05: 3.1M
- 2023-06: 3.4M
- 2023-07: 2.5M
- 2023-08: 2.8M
- 2023-09: 6.7M
- 2023-10: 1.9M
- 2023-11: 5.4M
- 2023-12: 3.1M
- 2024-02: 8.1M
- 2024-03: 3.1M
- 2024-05: 5.5M
- 2024-06: 3.3M
- 2024-07: 3M
- 2024-08: 1.3M
- 2024-09: 2.5M
- 2024-10: 2.2M
- 2024-11: 2M
- 2024-12: 1.8M
- 2025-01: 4.7M
- 2025-02: 1M
- 2025-03: 2.5M
- 2025-04: 2.9M
- 2025-05: 2.5M
- 2025-06: 1.9M
- 2025-07: 3M
- 2025-08: 1.3M
- 2025-09: 2.8M
- 2025-10: 661.9K
- 2025-11: 2M
- 2025-12: 3.1M
- 2026-01: 1.9M
- 2026-03: 697.5K
- 2026-04: 3.1M
- 2026-05: 1.7M
- 2026-06: 1.3M
- 2026-07: 799.3K
- 2026-08: 117.8K
- Main export countries
- India (0.6%)
- Sri Lanka (0%)
- Namibia (0%)
- Mexico (99.3%)
- Transactions
231
2018-012021-052025-08Transaction trend for Zoetis Suzhou Mfg Co., Ltd.
- 2018-01: 4
- 2018-02: 3
- 2018-03: 4
- 2018-04: 1
- 2018-05: 2
- 2018-06: 4
- 2018-07: 1
- 2018-09: 4
- 2018-11: 2
- 2018-12: 3
- 2019-01: 9
- 2019-02: 4
- 2019-03: 3
- 2019-04: 7
- 2019-05: 8
- 2019-06: 3
- 2019-07: 7
- 2019-08: 4
- 2019-09: 1
- 2019-10: 5
- 2019-11: 7
- 2020-01: 2
- 2020-03: 2
- 2020-04: 7
- 2020-05: 7
- 2020-06: 4
- 2020-09: 4
- 2020-11: 7
- 2021-03: 2
- 2021-04: 1
- 2021-05: 10
- 2021-06: 3
- 2021-07: 2
- 2021-09: 2
- 2021-10: 2
- 2021-11: 2
- 2022-04: 2
- 2022-05: 2
- 2022-07: 2
- 2022-10: 2
- 2022-11: 4
- 2022-12: 1
- 2023-03: 1
- 2023-04: 2
- 2023-06: 2
- 2023-09: 4
- 2024-01: 1
- 2024-04: 5
- 2024-05: 13
- 2024-06: 10
- 2024-07: 4
- 2024-08: 5
- 2024-09: 3
- 2024-10: 6
- 2024-11: 8
- 2024-12: 2
- 2025-01: 2
- 2025-02: 1
- 2025-03: 1
- 2025-04: 1
- 2025-05: 3
- 2025-08: 1
- Amount
564,082.25
2018-012021-052025-08Amount trend for Zoetis Suzhou Mfg Co., Ltd.
- 2018-01: 2.4M
- 2018-02: 788K
- 2018-03: 1.2M
- 2018-04: 3.2M
- 2018-05: 95.9K
- 2018-06: 941K
- 2018-07: 13.3M
- 2018-09: 1.3M
- 2018-11: 2M
- 2018-12: 1.8M
- 2019-01: 5.5B
- 2019-02: 273.6K
- 2019-03: 292.8K
- 2019-04: 648.4K
- 2019-05: 2.9M
- 2019-06: 2.1M
- 2019-07: 6.3M
- 2019-08: 3.3M
- 2019-09: 94.7K
- 2019-10: 465.6K
- 2019-11: 617.2K
- 2020-01: 108.3K
- 2020-03: 165.6K
- 2020-04: 437.4K
- 2020-05: 503.9K
- 2020-06: 169K
- 2020-09: 352K
- 2020-11: 629.8K
- 2021-03: 180.9K
- 2021-04: 27.6K
- 2021-05: 709.9K
- 2021-06: 431.7K
- 2021-07: 64K
- 2021-09: 28K
- 2021-10: 3.2M
- 2021-11: 4.3M
- 2022-04: 83.1K
- 2022-05: 72.9K
- 2022-07: 4.7M
- 2022-10: 2.3M
- 2022-11: 4.3M
- 2022-12: 30.7K
- 2023-03: 4.1M
- 2023-04: 80.3K
- 2023-06: 7.5M
- 2023-09: 240.3K
- 2024-01: 0
- 2024-04: 4.6M
- 2024-05: 112K
- 2024-06: 2.4M
- 2024-07: 242.3K
- 2024-08: 9.7M
- 2024-09: 268.5K
- 2024-10: 8.3M
- 2024-11: 13.4M
- 2024-12: 431.2K
- 2025-01: 124.8K
- 2025-02: 193.3K
- 2025-03: 193.9K
- 2025-04: 64.6K
- 2025-05: 10.9M
- 2025-08: 36.7K
- Main export countries
- Peru (0.5%)
- Indonesia (97.8%)
- United States (0.9%)
- Not available (0.9%)
- Transactions
47
2019-012020-102021-09Transaction trend for Puyang Hotway Pharmacy Co., Ltd.
- 2019-01: 32
- 2019-11: 2
- 2020-04: 2
- 2020-05: 1
- 2020-06: 1
- 2020-10: 1
- 2021-03: 2
- 2021-04: 1
- 2021-05: 1
- 2021-07: 1
- 2021-08: 1
- 2021-09: 2
- Amount
559,462.81
2019-012020-102021-09Amount trend for Puyang Hotway Pharmacy Co., Ltd.
- 2019-01: 5.6B
- 2019-11: 24.9K
- 2020-04: 22.1K
- 2020-05: 11.8K
- 2020-06: 12.3K
- 2020-10: 11.9K
- 2021-03: 24.6K
- 2021-04: 12.5K
- 2021-05: 12.7K
- 2021-07: 12.5K
- 2021-08: 12.5K
- 2021-09: 25.3K
- Main export countries
- Indonesia (100%)
Intelligence
China export momentum, destination markets, and regional demand.
China export trend
China export trend
- Date 2018-07: Value 3.3B USD
- Date 2018-08: Value 3.2B USD
- Date 2018-09: Value 3B USD
- Date 2018-10: Value 3B USD
- Date 2018-11: Value 3.7B USD
- Date 2018-12: Value 3.6B USD
- Date 2019-01: Value 3.5B USD
- Date 2019-02: Value 2.3B USD
- Date 2019-03: Value 3.5B USD
- Date 2019-04: Value 3.8B USD
- Date 2019-05: Value 4.2B USD
- Date 2019-06: Value 3.5B USD
- Date 2019-07: Value 3.8B USD
- Date 2019-08: Value 3.6B USD
- Date 2019-09: Value 3.7B USD
- Date 2019-10: Value 4B USD
- Date 2019-11: Value 4.3B USD
- Date 2019-12: Value 4.4B USD
- Date 2020-01: Value 0 USD
- Date 2020-02: Value 6.4B USD
- Date 2020-03: Value 4.7B USD
- Date 2020-04: Value 4.4B USD
- Date 2020-05: Value 3.8B USD
- Date 2020-06: Value 0 USD
- Date 2020-07: Value 0 USD
- Date 2020-08: Value 0 USD
- Date 2020-09: Value 4.2B USD
- Date 2020-10: Value 3.2B USD
- Date 2020-11: Value 3.8B USD
- Date 2020-12: Value 3.6B USD
- Date 2021-01: Value 264M USD
- Date 2021-02: Value 224M USD
- Date 2021-03: Value 281M USD
- Date 2021-04: Value 284M USD
- Date 2021-05: Value 266M USD
- Date 2021-06: Value 265M USD
- Date 2021-07: Value 292M USD
- Date 2021-08: Value 260M USD
- Date 2021-09: Value 301M USD
- Date 2021-10: Value 296M USD
- Date 2021-11: Value 308M USD
- Date 2021-12: Value 326M USD
- Date 2022-01: Value 338M USD
- Date 2022-02: Value 246M USD
- Date 2022-03: Value 358M USD
- Date 2022-04: Value 308M USD
- Date 2022-05: Value 325M USD
- Date 2022-06: Value 317M USD
- Date 2022-07: Value 332M USD
- Date 2022-08: Value 314M USD
- Date 2022-09: Value 311M USD
- Date 2022-10: Value 276M USD
- Date 2022-11: Value 322M USD
- Date 2022-12: Value 286M USD
- Date 2023-01: Value 276M USD
- Date 2023-02: Value 255M USD
- Date 2023-03: Value 310M USD
- Date 2023-04: Value 292M USD
- Date 2023-05: Value 324M USD
- Date 2023-06: Value 307M USD
- Date 2023-07: Value 267M USD
- Date 2023-08: Value 300M USD
- Date 2023-09: Value 312M USD
- Date 2023-10: Value 244M USD
- Date 2023-11: Value 294M USD
- Date 2023-12: Value 325M USD
- Date 2024-01: Value 457M USD
- Date 2024-02: Value 311M USD
- Date 2024-03: Value 417M USD
- Date 2024-04: Value 377M USD
- Date 2024-05: Value 328M USD
- Date 2024-06: Value 441M USD
- Date 2024-07: Value 404M USD
- Date 2024-08: Value 423M USD
- Date 2024-09: Value 396M USD
- Date 2024-10: Value 375M USD
- Date 2024-11: Value 430M USD
- Date 2024-12: Value 488M USD
- Date 2025-01: Value 471M USD
- Date 2025-02: Value 318M USD
- Date 2025-03: Value 437M USD
- Date 2025-04: Value 432M USD
- Date 2025-05: Value 429M USD
- Date 2025-06: Value 442M USD
- Date 2025-07: Value 451M USD
- Date 2025-08: Value 424M USD
- Date 2025-09: Value 445M USD
- Date 2025-10: Value 314M USD
- Date 2025-11: Value 470M USD
- Date 2025-12: Value 470M USD
- Date 2026-01: Value 511M USD
- Date 2026-02: Value 363M USD
- Date 2026-03: Value 434M USD
- Date 2026-04: Value 466M USD
- Date 2026-05: Value 424M USD
- Date 2026-06: Value 513M USD
- Date 2026-07: Value 472M USD
Top destinations
- Germany23.1B
- United States13.6B
- Italy8.5B
- France8.3B
- Sweden6.9B
- Japan5.5B
- United Kingdom5B
- Switzerland3.5B
- Australia3.2B
- Ireland2.8B
Top destinations
- Germany: 23,069,000,000 USD
- United States: 13,594,000,000 USD
- Italy: 8,537,000,000 USD
- France: 8,306,000,000 USD
- Sweden: 6,944,000,000 USD
- Japan: 5,451,000,000 USD
- United Kingdom: 4,985,000,000 USD
- Switzerland: 3,463,000,000 USD
- Australia: 3,248,000,000 USD
- Ireland: 2,760,000,000 USD
Key findings
Largest import market
23.07B USD
Germany · last 8 years
Fastest demand growth
84,913.74
Montenegro · last 8 years
Highest unit price
$2,523.67 /kg
Sweden · +21,722.17% vs avg
Turn this market into qualified conversations.
Your agent contacts, compares, and screens the suppliers that fit.
Insights
Product insights to guide your sourcing.
Product Trends
Lyophilized powder injections and combination oral preparations, such as amoxicillin-clavulanate, are seeing strong demand growth. Advanced extended-release oral tablets are also gaining significant traction due to improved patient compliance and stable therapeutic release profiles.
Industrial Cluster Analysis
Shijiazhuang and Zhejiang's Taizhou are China's core clusters for anti-infectives. Shijiazhuang excels in large-scale antibiotic production, ideal for bulk public tenders. Taizhou specializes in high-standard export preparations, matching customized, highly regulated markets.
Quality Expectations
Target markets expect anti-infective drugs to match reference drugs in bioequivalence. Preparations must maintain strictly low impurity profiles and pass stability testing under specific climatic zones (such as Zone IVb) to ensure safety and effectiveness throughout their shelf life.
What You Need to Know
Buyers should request Certificate of Analysis (CoA) batches, method validation reports, and a sample of the finished dosage form. Conducting a virtual or third-party GMP audit of the manufacturing facility is also highly recommended to verify production consistency.
The MOQ typically starts from 50,000 to 100,000 packs per formulation or depends on the minimum commercial batch size of the production line. Delivery usually takes 60 to 90 days, mainly determined by raw material procurement, strict quality release testing, and packaging customization.
Buyers should budget for regulatory registration fees, translation of tech transfer dossiers, stability testing under specific climates, custom packaging plate costs, and third-party pre-shipment inspection. Ensure terms clarify which party covers local drug registration expenses.
